Filing metadata

Accession number
0000899243-22-008099
Form type
Form 3
Filer
Amylyx Pharmaceuticals, Inc.
CIK
CIK 1658551
Filed
Feb 28, 2022
Reporting period
Feb 22, 2022
Description
Initial ownership

Explore SEC Filings Hub